Temasek Invests in Gene Editing Food Company Pairwise

Posted on 02/04/2021

Gene editing food companies are gaining the attention of institutional investors. Durham, North Carolina-based Pairwise raised US$ 90 million in a Series B funding round. Funding for the round was led by Pontifax Global Food and Agriculture Technology Fund (Pontifax AgTech), and existing investor Deerfield Management Company. Singapore’s Temasek Holdings also invested in the Series B round as a new investor. Existing investor Leaps by Bayer also participated in the round as well.

Pairwise uses CRISPR technology to create new fruits and vegetables. Wilson Sonsini Goodrich & Rosati advised Temasek Holdings in the transaction.

Pairwise announced US$ 25 million in Series A funding in March 2018, led by Deerfield and what is now Leaps by Bayer, to develop its gene editing platform and initial product portfolio.

Get News, People, and Transactions, Delivered to Your Inbox